Alekseev A G, Pichugin A A, Danilov V I
Kazan State Medical University, Kazan, Republic of Tatarstan, Russia; Interregional Clinical and Diagnostic Center, Kazan, Republic of Tatarstan, Russia.
Zh Vopr Neirokhir Im N N Burdenko. 2017;81(5):36-45. doi: 10.17116/neiro201781536-45.
to analyze 31 resections of chiasmatic-sellar region (CSR) and anterior cranial fossa (ACF) tumors using the supraorbital trans-eyebrow approach (STA).
We analyzed medical histories of 31 patients who underwent tumor resection using STA in the period between October 2013 and April 2017. We analyzed the age and gender of patients, size and location of the tumor, presence of a neurological deficit, vision and olfactory functions before and after surgery, surgery duration, amount of intraoperative blood loss, rate of frontal sinus trephination and nasal liquorrhea, hemorrhagic and ischemic complications after surgery, Simpson grade of tumor resection, patient's condition before and after surgery (Glasgow Outcome Scale and Karnofsky Scale), and degree of patient satisfaction with the cosmetic result of surgery. A total of 26 meningiomas (20 sphenoid plate, tubercle, and diaphragm tumors, 3 lesser sphenoid wing meningiomas, 2 orbital roof tumors, and 1 anterior clinoid process meningioma), 3 frontal lobe gliomas, and 2 pituitary adenomas were resected.
In all 31 operations, the approach was adequate and enabled tumor resection without lethal outcomes. The mean surgery duration was 174.6±64.4 min. The mean blood loss was 190±96.6 mL (50-380 mL). After surgery, none of the patients developed motor deficits and new epileptic seizures. Neurological deficit aggravation in the form of impaired vision and mental disorders occurred in 8 (25.8%) patients. Vision impaired in 4 (12.9%) patients, improved in 6 (19.3%) patients, and remained unchanged in 21 (67.7%) patients. An endocrinological deficit in the form of partial hypopituitarism developed in 3 (9.6%) patients; in 4 (12.9%) patients, there were mental disorders that regressed by the end of the first month of therapy. There were no intracerebral and subarachnoid hemorrhages. In 2 (6.4%) patients, small epidural hematomas were diagnosed, which did not require surgical treatment. There were only good outcomes (a GOS score of 4 or 5). After surgery, the median Karnofsky index in the STA group was 90±7. In all 31 (100%) patients, the postoperative wound healed by primary intention, without infectious complications and wound liquorrhea. One (4%) patient developed eyebrow palsy; 3 (12%) patients had hypoesthesia in the supraorbital region. The mean VAS score of patient satisfaction with the cosmetic result was 9.36 (median 10±1). The mean follow-up period was 16.2±13.5 months (2-38 months).
The STA is adequate for removal of CSR and ACF tumors under proper selection of patients. It provides an adequate view of anatomical structures and enables successful tumor resection through a less traumatic access.
采用眶上经眉弓入路(STA)分析31例视交叉 - 鞍区(CSR)及前颅窝(ACF)肿瘤切除术。
我们分析了2013年10月至2017年4月期间31例行STA肿瘤切除术患者的病历。分析了患者的年龄和性别、肿瘤大小和位置、神经功能缺损情况、手术前后的视力和嗅觉功能、手术时长、术中失血量、额窦钻孔率和鼻漏情况、术后出血和缺血性并发症、肿瘤切除的辛普森分级、手术前后患者的状况(格拉斯哥预后量表和卡诺夫斯基量表)以及患者对手术美容效果的满意度。共切除26例脑膜瘤(20例蝶骨平台、结节和鞍膈肿瘤,3例蝶骨嵴内侧脑膜瘤,2例眶顶肿瘤,1例前床突脑膜瘤)、3例额叶胶质瘤和2例垂体腺瘤。
在所有31例手术中,该入路均合适,能够完成肿瘤切除且无致命后果。平均手术时长为174.6±64.4分钟。平均失血量为190±96.6毫升(50 - 380毫升)。术后,所有患者均未出现运动功能缺损和新发癫痫发作。8例(25.8%)患者出现以视力受损和精神障碍形式的神经功能缺损加重。4例(12.9%)患者视力受损,6例(19.3%)患者视力改善,21例(67.7%)患者视力无变化。3例(9.6%)患者出现部分垂体功能减退形式的内分泌功能缺损;4例(12.9%)患者出现精神障碍,在治疗第一个月末病情缓解。未发生脑内和蛛网膜下腔出血。2例(6.4%)患者诊断为小的硬膜外血肿,无需手术治疗。仅获得良好预后(格拉斯哥预后量表评分为4或5)。术后,STA组的卡诺夫斯基指数中位数为90±7。所有31例(100%)患者术后伤口一期愈合,无感染并发症和伤口渗液。1例(4%)患者出现眉下垂;3例(12%)患者眶上区感觉减退。患者对美容效果的满意度视觉模拟评分(VAS)平均为9.36(中位数10±1)。平均随访期为16.2±13.5个月(2 - 38个月)。
在适当选择患者的情况下,STA适用于切除CSR和ACF肿瘤。它能提供足够的解剖结构视野,并通过创伤较小的入路成功切除肿瘤。